Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Title
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Authors
Keywords
-
Journal
LANCET
Volume 397, Issue 10275, Pages 671-681
Publisher
Elsevier BV
Online
2021-02-03
DOI
10.1016/s0140-6736(21)00234-8

Ask authors/readers for more resources

Reprint

Contact the author